Education

Scientific interest in psilocybin microdosing has increased, but researchers emphasize that safety data remains limited. Most existing studies were not designed to assess long-term exposure, repeated use, or cumulative effects. As a result, public health agencies caution that conclusions about safety should be considered preliminary (National Institute on Drug Abuse). One of the primary unknowns …

Microdosing Safety, Frequency, and What Remains Unknown Read More »

Brain imaging has become a central tool in modern psychedelic research, but its application to microdosing remains limited. While full-dose psilocybin studies frequently use imaging techniques to observe changes in brain networks, researchers caution that microdosing presents unique measurement challenges due to the subtle nature of the doses involved (National Institutes of Health). Most neuroimaging …

Brain Imaging and Microdosing Research Read More »

One of the most consistent findings in microdosing research is the powerful role of expectation. Scientists have long known that belief alone can influence how people perceive mood, focus, and well-being. In microdosing studies, this effect appears especially strong, making it difficult to separate true pharmacological effects from placebo responses (National Institutes of Health). Placebo …

Microdosing, Placebo Effects, and Expectation Read More »

Microdosing refers to the practice of taking very small amounts of a substance at doses intended to avoid noticeable perceptual effects. In recent years, microdosing psilocybin has gained attention in public discourse, but scientific research on the topic remains limited and mixed. Researchers emphasize that interest has grown faster than high-quality evidence (National Institutes of …

Microdosing Psilocybin: What Research Shows Read More »

Psilocybin access in the United States exists through two very different pathways: clinical research access and limited public access under state-regulated programs. These pathways are governed by separate legal authorities, oversight structures, and eligibility requirements. Understanding this distinction is critical for accurate public education and legal clarity. Research access refers to psilocybin use that occurs …

Research Access vs Public Access Explained Read More »

Public discussion around psilocybin often uses the terms decriminalization and legalization interchangeably, but in law and policy they mean very different things. Researchers, lawmakers, and public agencies emphasize that misunderstanding this distinction can lead to legal risk and misinformation (National Conference of State Legislatures). Decriminalization typically means reducing or eliminating criminal penalties for certain activities, …

Decriminalization vs Legalization Explained Read More »

Oregon and Colorado are currently the only U.S. states with statewide frameworks allowing regulated psilocybin services. These programs are often misunderstood as “legalization,” but state officials stress that they operate as tightly controlled public health models and do not override federal law. Oregon established the first statewide program through Measure 109, approved by voters in 2020. The program …

Oregon and Colorado Psilocybin Programs Explained Read More »

Psilocybin remains illegal under United States federal law. It is classified as a Schedule I substance under the Controlled Substances Act, meaning it is defined as having no currently accepted medical use and a high potential for abuse. This classification applies regardless of state or local policy changes and makes non-research possession, distribution, or manufacturing …

Psilocybin Legal Status in the United States Read More »

One of the most serious safety risks associated with mushrooms is misidentification. Many toxic mushroom species closely resemble psilocybin-containing mushrooms, making visual identification unreliable. Public health agencies emphasize that accidental ingestion of poisonous mushrooms can result in severe illness, organ failure, or death (Centers for Disease Control and Prevention). Several deadly mushroom species, including Amanita …

Mushroom Misidentification and Environmental Risks Read More »

In psilocybin research, scientists often refer to the concepts of “set” and “setting” when discussing psychological safety and variability in outcomes. These terms describe the internal and external factors that influence how individuals respond during clinical studies. Researchers emphasize that understanding set and setting is essential for minimizing risk and interpreting research results accurately (National …

Set and Setting in Psilocybin Research Read More »